Furthermore, the Akt/mTOR signaling pathway is frequently altered in certain types of cancer, including gastric cancer, prostate cancer, cervical carcinoma, renal cell carcinoma, lung carcinoma and pancreatic ductal adenocarcinoma (21–25). The gene discussed is AKT1; the disease is prostate cancer.